Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Levothyroxine Sodium Tablets, USP


Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

Sections Modified

PRECAUTIONS

  • Information for Patients
    • ...It is very important that you take the tablet with a full glass of water.
    • Agents such as iron and calcium supplements and antacids can decrease the absorption of levothyroxine sodium tablets...
  • Drug Interactions
    • Table 2: Drug-Thyroidal Axis Interactions
      • Drugs that may decrease T4 absorption, which may result in hypothyroidism
        • Orlistat

Label not available on Drugs@FDA

 

-
-